ATE318823T1 - Pharmazeutisch geeignete salze von 20(s)- camptothecinen - Google Patents
Pharmazeutisch geeignete salze von 20(s)- camptothecinenInfo
- Publication number
- ATE318823T1 ATE318823T1 AT02772643T AT02772643T ATE318823T1 AT E318823 T1 ATE318823 T1 AT E318823T1 AT 02772643 T AT02772643 T AT 02772643T AT 02772643 T AT02772643 T AT 02772643T AT E318823 T1 ATE318823 T1 AT E318823T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- acid
- sup
- alkylamino
- substituent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN798MA2001 | 2001-09-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE318823T1 true ATE318823T1 (de) | 2006-03-15 |
Family
ID=33042623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02772643T ATE318823T1 (de) | 2001-09-25 | 2002-09-25 | Pharmazeutisch geeignete salze von 20(s)- camptothecinen |
Country Status (18)
Country | Link |
---|---|
US (1) | US7071203B2 (de) |
EP (1) | EP1430059B1 (de) |
JP (1) | JP2005507893A (de) |
KR (1) | KR20040039404A (de) |
CN (1) | CN1575292A (de) |
AT (1) | ATE318823T1 (de) |
BR (1) | BR0212990A (de) |
CA (1) | CA2461089A1 (de) |
DE (1) | DE60209517D1 (de) |
HU (1) | HUP0401912A3 (de) |
IL (1) | IL160982A0 (de) |
MX (1) | MXPA04002784A (de) |
NO (1) | NO20041643L (de) |
NZ (1) | NZ531878A (de) |
PL (1) | PL368229A1 (de) |
RU (1) | RU2004109163A (de) |
WO (1) | WO2003027118A1 (de) |
ZA (1) | ZA200402321B (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003068778A1 (en) * | 2002-02-18 | 2003-08-21 | Dr. Reddy's Laboratories Limited | A process for the preparation of 10-hydroxy-9-n,n-dimethylaminomethyl-5-(2'-fluoroethoxy)-20(s)-camptothecin hydrochloride |
TWI333492B (en) | 2003-11-12 | 2010-11-21 | Smithkline Beecham Cork Ltd | Crystalline topotecan hydrochloride product and preparation thereof |
EP1798235B1 (de) * | 2004-10-01 | 2015-04-01 | Kabushiki Kaisha Yakult Honsha | Säureadditionssalz von irinotecan |
ITMI20061473A1 (it) * | 2006-07-26 | 2008-01-27 | Indena Spa | Derivati della camptotecina ad attivita antitumorale |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1025029C (zh) * | 1988-10-22 | 1994-06-15 | 沈阳药学院 | 喜树硷精氨酸盐制剂的制备方法 |
US6177439B1 (en) * | 1995-06-06 | 2001-01-23 | Reddy's Research Foundation | Water soluble analogues of 20(S)-camptothecin |
JP4094710B2 (ja) * | 1997-11-06 | 2008-06-04 | 株式会社ヤクルト本社 | 新規なカンプトテシン誘導体 |
-
2002
- 2002-09-25 MX MXPA04002784A patent/MXPA04002784A/es unknown
- 2002-09-25 WO PCT/IB2002/003950 patent/WO2003027118A1/en active IP Right Grant
- 2002-09-25 US US10/490,552 patent/US7071203B2/en not_active Expired - Fee Related
- 2002-09-25 JP JP2003530706A patent/JP2005507893A/ja not_active Withdrawn
- 2002-09-25 RU RU2004109163/04A patent/RU2004109163A/ru not_active Application Discontinuation
- 2002-09-25 IL IL16098202A patent/IL160982A0/xx unknown
- 2002-09-25 BR BR0212990-6A patent/BR0212990A/pt not_active IP Right Cessation
- 2002-09-25 KR KR10-2004-7004255A patent/KR20040039404A/ko not_active Application Discontinuation
- 2002-09-25 CN CNA028210840A patent/CN1575292A/zh active Pending
- 2002-09-25 CA CA002461089A patent/CA2461089A1/en not_active Abandoned
- 2002-09-25 PL PL02368229A patent/PL368229A1/xx not_active Application Discontinuation
- 2002-09-25 AT AT02772643T patent/ATE318823T1/de not_active IP Right Cessation
- 2002-09-25 HU HU0401912A patent/HUP0401912A3/hu unknown
- 2002-09-25 DE DE60209517T patent/DE60209517D1/de not_active Expired - Lifetime
- 2002-09-25 NZ NZ531878A patent/NZ531878A/en unknown
- 2002-09-25 EP EP02772643A patent/EP1430059B1/de not_active Expired - Lifetime
-
2004
- 2004-03-24 ZA ZA200402321A patent/ZA200402321B/xx unknown
- 2004-04-22 NO NO20041643A patent/NO20041643L/no unknown
Also Published As
Publication number | Publication date |
---|---|
WO2003027118A1 (en) | 2003-04-03 |
US7071203B2 (en) | 2006-07-04 |
MXPA04002784A (es) | 2004-07-29 |
JP2005507893A (ja) | 2005-03-24 |
EP1430059A1 (de) | 2004-06-23 |
KR20040039404A (ko) | 2004-05-10 |
DE60209517D1 (de) | 2006-04-27 |
PL368229A1 (en) | 2005-03-21 |
CA2461089A1 (en) | 2003-04-03 |
NZ531878A (en) | 2006-04-28 |
IL160982A0 (en) | 2004-08-31 |
NO20041643L (no) | 2004-04-22 |
BR0212990A (pt) | 2004-09-21 |
US20040198760A1 (en) | 2004-10-07 |
EP1430059B1 (de) | 2006-03-01 |
HUP0401912A2 (hu) | 2005-01-28 |
RU2004109163A (ru) | 2005-10-10 |
ZA200402321B (en) | 2005-01-13 |
CN1575292A (zh) | 2005-02-02 |
HUP0401912A3 (en) | 2007-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE283253T1 (de) | Substituierte aminopropoxyarylderivate als lxr agonisten | |
DK0674631T3 (da) | Substituerede pyrazoler som CRF-antogonister | |
CY1114875T1 (el) | Μεθοδος για παραγωγη παραγωγου αμινοθειαζολιου και παραγωγη ενδιαμεσου | |
KR940018381A (ko) | 퀴놀린 또는 퀴나졸린 유도체, 그 제조 및 용도 | |
ATE296300T1 (de) | Benzoheterocyclische distamycinderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel | |
PL362766A1 (en) | Novel imidazole derivatives, production method thereof and use thereof | |
ATE318823T1 (de) | Pharmazeutisch geeignete salze von 20(s)- camptothecinen | |
NO20051009L (no) | Syntese av indoliziner | |
BR0307008A (pt) | N-aril-4,5-dia-minopirazóis e agentes de tingimento que contêm esses compostos | |
NO330965B1 (no) | Fremgangsmate for fremstilling av substituerte imidazolderivater, mellomprodukter anvendt i fremgangsmaten samt fremgangsmate for fremstilling av mellomprodukt | |
NO20023298D0 (no) | Nye imidazolderivater | |
EE05136B1 (et) | Asendatud imidasopridiinhendite valmistamise meetod | |
EA200500028A1 (ru) | Новые соединения 3-(4-оксо-4h-хромен-2-ил)-(1h)-хинолин-4-она, способ их получения и фармацевтические композиции, которые их содержат | |
BR0208324A (pt) | Compostos, processo de preparação de compostos, e, composições farmacêuticas | |
ATE206125T1 (de) | Furoindolizine | |
DE60108242D1 (de) | Herstellung von hydroxyverbindungen | |
EE200300222A (et) | 4-(17a-asendatud-3-oksoöstra-4,9-dieen-11ß-üül)-bensaldehüüd-(1E või 1Z)-oksiimide valmistamismeetod | |
HUP0301741A2 (hu) | Eljárás 4-bróm-anilin-származékok előállítására | |
BR0317337B1 (pt) | Compostos e composições repelentes de praga | |
TR200402333T4 (tr) | Artropodisidal karboksanilidler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |